Orylmyte 300 IR Sublingualtabletten
Country: Germany
Language: German
Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Dermatophagoides-pteronyssinus-Allergen; Dermatophagoides-farinae-Allergen
Available from:
kohlpharma GmbH (3216120)
Dosage:
300 IR
Pharmaceutical form:
Sublingualtablette
Composition:
Teil 1 - Sublingualtablette; Dermatophagoides-pteronyssinus-Allergen (31454) 150 Reaktivitätsindex; Dermatophagoides-farinae-Allergen (31453) 150 Reaktivitätsindex
Administration route:
Sublingual
Authorization status:
zugelassen
Authorization date:
2022-08-02
